Abstract Objective To study the association of maternal methylenetetrahydrofolate dehydrogenase 1 (MTHFD1) and methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) gene polymorphisms with congenital heart disease (CHD) in offspring. Methods A hospital-based case-control study was conducted. The mothers of 683 children with CHD alone who attended Hunan Children's Hospital, from November 2017 to March 2020 were enrolled as the case group, and the mothers of 740 healthy children who attended the same hospital during the same period and did not have any deformity were enrolled as the control group. A questionnaire survey was performed to collect related exposure data, and then venous blood samples (5 mL) were collected from the mothers to detect MTHFD1 and MTHFD2 gene polymorphisms. A multivariate logistic regression analysis was used to evaluate the association of MTHFD1 and MTHFD2 gene polymorphisms with CHD. The four-gamete test in Haploview 4.2 software was used to construct haplotypes and evaluate the association between haplotypes and CHD. The generalized multifactor dimensionality reduction method and logistic regression analysis were used to examine gene-gene interaction and its association with CHD. Results The multivariate logistic regression analysis showed that maternal MTHFD1 gene polymorphisms at rs11849530 (GA vs AA: OR=1.49; GG vs AA: OR=2.04) and at rs1256142 (GA vs GG: OR=2.34; AA vs GG: OR=3.25) significantly increased the risk of CHD in offspring (P<0.05), while maternal MTHFD1 gene polymorphisms at rs1950902 (AA vs GG: OR=0.57) and MTHFD2 gene polymorphisms at rs1095966 (CA vs CC: OR=0.68) significantly reduced the risk of CHD in offspring (P<0.05). The haplotypes of G-G-G (OR=1.86) and G-A-G (OR=1.35) in mothers significantly increased the risk of CHD in offspring (P<0.05). The gene-gene interaction analyses showed that the first-order interaction between MTHFD1 rs1950902 and MTHFD1 rs2236222 and the second-order interaction involving MTHFD1 rs1950902, MTHFD1 rs1256142, and MTHFD2 rs1095966 might be associated with risk of CHD (P<0.05). Conclusions Maternal MTHFD1 and MTHFD2 gene polymorphisms and their haplotypes, as well as the interaction between MTHFD1 rs1950902 and MTHFD1 rs2236222 and between MTHFD1 rs1950902, MTHFD1 rs1256142, and MTHFD2 rs1095966, are associated with the risk of CHD in offspring.
CHEN Qian,HUANG Peng,SONG Xin-Li et al. Association of maternal MTHFD1 and MTHFD2 gene polymorphisms with congenital heart disease in offspring[J]. CJCP, 2022, 24(7): 797-805.
CHEN Qian,HUANG Peng,SONG Xin-Li et al. Association of maternal MTHFD1 and MTHFD2 gene polymorphisms with congenital heart disease in offspring[J]. CJCP, 2022, 24(7): 797-805.
Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of congenital heart defects 1970-2017: updated systematic review and meta-analysis of 260 studies[J]. Int J Epidemiol, 2019, 48(2): 455-463. PMID: 30783674. PMCID: PMC6469300. DOI: 10.1093/ije/dyz009.
Moreau JLM, Kesteven S, Martin EMMA, et al. Gene-environment interaction impacts on heart development and embryo survival[J]. Development, 2019, 146(4): dev172957. PMID: 30787001. DOI: 10.1242/dev.172957.
Qu Y, Lin S, Zhuang J, et al. First-trimester maternal folic acid supplementation reduced risks of severe and most congenital heart diseases in offspring: a large case-control study[J]. J Am Heart Assoc, 2020, 9(13): e015652. PMID: 32613868. PMCID: PMC7670504. DOI: 10.1161/JAHA.119.015652.
Song X, Li Q, Diao J, et al. Association of MTHFD1 gene polymorphisms and maternal smoking with risk of congenital heart disease: a hospital-based case-control study[J]. BMC Pregnancy Childbirth, 2022, 22(1): 88. PMID: 35100977. PMCID: PMC8805321. DOI: 10.1186/s12884-022-04419-2.
Khatami M, Ratki FM, Tajfar S, et al. Relationship of the MTHFD1 (rs2236225), eNOS (rs1799983), CBS (rs2850144) and ACE (rs4343) gene polymorphisms in a population of Iranian pediatric patients with congenital heart defects[J]. Kaohsiung J Med Sci, 2017, 33(9): 442-448. PMID: 28865601. DOI: 10.1016/j.kjms.2017.05.016.
Wang B, Liu M, Yan W, et al. Association of SNPs in genes involved in folate metabolism with the risk of congenital heart disease[J]. J Matern Fetal Neonatal Med, 2013, 26(18): 1768-1777. PMID: 23701284. DOI: 10.3109/14767058.2013.799648.
Christensen KE, Rohlicek CV, Andelfinger GU, et al. The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects[J]. Hum Mutat, 2009, 30(2): 212-220. PMID: 18767138. DOI: 10.1002/humu.20830.
Jiang YC, Kuang LL, Sun SN, et al. Association of genetic polymorphisms of de novo nucleotide biosynthesis with increased CHD susceptibility in the northern Chinese population[J]. Clin Genet, 2017, 91(5): 748-755. PMID: 27659940. DOI: 10.1111/cge.12874.
18 许晶. 基因区域多态性与先天性心脏病发病关系研究[D]. 南京: 南京医科大学, 2010.
Xu J, Xu X, Xue L, et al. MTHFR c.1793G>A polymorphism is associated with congenital cardiac disease in a Chinese population[J]. Cardiol Young, 2010, 20(3): 318-326. PMID: 20374669. DOI: 10.1017/S1047951110000247.
Cheng J, Zhu WL, Dao JJ, et al. Relationship between polymorphism of methylenetetrahydrofolate dehydrogenase and congenital heart defect[J]. Biomed Environ Sci, 2005, 18(1): 58-64. PMID: 15861780.